2026 TeoTwawKi ... 2032 Darkest Interregnum Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum

GLD 383.12

+0.8%

Nov 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

maceng2

To: maceng2 who wrote (181492)	12/19/2021 9:26:07 PM
From: Pogeu Mahone	1 Recommendation Read Replies (1) of 218050

Pfizer COVID-19 pill may not see approval for 'months' despite 'impressive' data. "It's going to be months," Fauci explained. "If you look, it's a very complicated synthetic process to make the drug. It is not something that's simple." fox35orlando.com current #vaccines even with #boosters are insufficient to neutralize live #omicron virus. As expected, pseudoviruses most labs are using are overestimating vaccine potency Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2 twitter.com biorxiv.org just announced that due to the prevalence of Omicron and its resistance to Monoclonal Antibodies they will no longer be providing them as treatment. We are literally back at the beginning. Without a single available early intervention. We knew this was coming!! twitter.com There is one Monoclonal Antibodies treatment that does work I think just approved but it is hard to get now, called Sotrovimab

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next